Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion

OBJECTIVE: Sodium–glucose cotransporter 2 (SGLT2) inhibition causes an increase in endogenous glucose production (EGP). However, the mechanisms are unclear. We studied the effect of SGLT2 inhibitors on EGP in subjects with type 2 diabetes (T2D) and without diabetes (non-DM) in kidney transplant reci...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Diabetes Care
Prif Awduron: Solis-Herrera, Carolina, Daniele, Giuseppe, Alatrach, Mariam, Agyin, Christina, Triplitt, Curtis, Adams, John, Patel, Rupal, Gastaldelli, Amalia, Honka, Henri, Chen, Xi, Abdul-Ghani, Muhammad, Cersosimo, Eugenio, Del Prato, Stephano, DeFronzo, Ralph
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Diabetes Association 2020
Pynciau:
Emerging Therapies: Drugs and Regimens
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7171949/
https://ncbi.nlm.nih.gov/pubmed/32144165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-2177
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg